The latest report found 19 states have adult obesity rates at or above 35% — that's down from 23 last year.

Please provide your email address to receive an email when new articles are posted on . Data from SURMOUNT-OSA and a prespecified analysis of the SELECT trial were among the biggest obesity studies in ...

Biohaven Ltd. downgraded after FDA CRL for troriluzole; see its pipeline shift to obesity/neurology, Phase 2 catalysts, and ...

Obesity therapeutics now represent ~$98B and 4.6% share, climbing to the fourth-largest category, with ~190 pipeline assets ...

Researchers projected that adult obesity rates in the U.S. will rise to 47% in the next decade. Women under age 35 had the largest increase in obesity prevalence from 1990 to 2022. Multifactorial ...

The disturbing statistics on childhood obesity in New Mexico should serve as a wake-up call to unite parents, public health experts, educators, doctors, lawmakers and farmers in a coordinated effort ...

Add Yahoo as a preferred source to see more of our stories on Google. It’s Tuesday morning and you’ve just washed your third Danish down with your fourth cup of coffee. Sound familiar? If so, there is ...

Obesity is linked to increased cancer risk through inflammation, metabolic dysfunction, and immune changes. Dr. Jennifer ...

Early prescription data for Eli Lilly and Co.'s LLY newly launched obesity pill suggest a measured start compared to Novo ...

JPMorgan says Viking Therapeutics (VKTX) released data on the higher doses of oral-2735 at ObesityWeek which exceeded expectations on both efficacy and tolerability. The highest dose of 100mg showed 8 ...

Wave Life Sciences (WVE) shares fell nearly 50% to $6.20 after BofA and Wells Fargo cut price targets to $21 and $13 respectively, citing insufficient data for WVE-007 as a standalone obesity ...

Incretin-based obesity medications may result in higher muscle-related loss vs. other weight loss strategies, according to ...